+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Simbrinza"

Antiglaucoma Drugs Market Report 2025 - Product Thumbnail Image

Antiglaucoma Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Glaucoma Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Glaucoma Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 360 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Simbrinza is a brand of eye drops used to treat glaucoma and ocular hypertension. It is a combination of two active ingredients, brinzolamide and brimonidine tartrate, which work together to reduce intraocular pressure. Simbrinza is a prescription medication and is available in both single-use and multi-dose bottles. It is typically used once or twice daily, depending on the severity of the condition. Simbrinza is part of a larger market of optical disorder drugs, which includes medications used to treat a variety of eye conditions, such as glaucoma, cataracts, and macular degeneration. These drugs are typically used to reduce intraocular pressure, improve vision, and slow the progression of the disease. Some companies in the Simbrinza market include Alcon, Bausch + Lomb, Allergan, and Santen Pharmaceuticals. Show Less Read more